F4/80 Monoclonal Antibody (BM8), eBioscience and 3 more items

Life Technologies Corporation was awarded contract A207_PO-0468702 by the University of Virginia on August 13, 2026, with a cumulative contract value of $834. The contracting organization is a Virginia-based institution, and the prime contractor is Life Technologies Corporation. While the specific products and services are not detailed in the available documentation, Life Technologies Corporation's core business operations suggest this procurement likely involves laboratory equipment, reagents, or life science products commonly supplied to academic research institutions.

The contract represents a purchase order arrangement with the University of Virginia serving as the contracting entity. The relatively modest contract value of $834 indicates this award covers a limited scope of goods or services. Specific details regarding the period of performance, exact place of performance beyond the University of Virginia's Virginia location, and the precise nature of deliverables are not provided in the source materials. Additional contract documentation would be required to establish comprehensive details about service delivery timelines and performance specifications.